TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 0 | 7 | -11 | -18 | -48 | -62 | -26 |
| P | %wins | 50 | 50 | 0 | 0 | 0 | 0 | 17 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/20/08 12:12 | 5/16/08 | AGEN | Antigenics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Margaret Eisen | CT | D | P | 35 | 2.36 | 0 | 15 | 300 | 20 | D | 38 | -8 | 7 | 0 | -23 | 1 | 0 | 1 | 1 | -1 | -17 | -15 | -70 | -72 | |
9/15/03 12:21 | 4/23/03 | AGEN | Antigenics Inc /de/ | DE | Health | BioPrd | Biological Products, (No Diag | Margaret Eisen | CT | D | P | 46 | 9.13 | 1 | 5 | New | 5 | D | -16 | 59 | 93 | -11 | 10 | 1 | 6 | -1 | -1 | 14 | -4 | -21 | -26 | -52 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |